Espicom market intelligence, brought to you by Business Monitor InternationalKenya Pharmaceuticals & Healthcare ReportA high birth rate due to limited birth control and the importance placed on having a large family by rural populations as a source of economic strength, as well as a growing disease burden, is likely to put further pressure on Kenya's healthcare infrastructure and human resources. In order to provide the country's citizens with sufficient care, it is vital that the government adopts a human resources strategy that incentivises medical workers so the sector can attract and retain staff.Headline Expenditure Projections Pharmaceuticals: KES41.74bn (US$470mn) in 2011 to KES49.70bn (US$577mn) in 2012; 19.1% growth in local currency terms and 22.9% in US dollar terms. Healthcare: KES135.01bn (US$ 1.52bn) in 2011 to KES151.00bn (US$1.75bn) in 2012; 11.8% growth in local currency terms and 15.8% in US dollar terms. Medical devices: KES7.19bn (US$81mn) in 2011 to KES7.68bn (US$89mn) in 2012; 6.8% growth in local currency terms and 10.2% in US dollar terms. Risk/Reward Rating: In BMI's Q113 Pharmaceutical and Healthcare Risk/Reward Ratings (RRRs), Kenya is 22nd in the Middle East and Africa (MEA) region, above Uganda, Nigeria and Mozambique. A large counterfeiting industry, poor healthcare funding, corruption, regulatory deficiencies and a number of other issues will conspire to keep Kenya in a lowly position in the MEA matrix. Nevertheless, in comparison with many other African markets, most of which are not surveyed by BMI, Kenya offers more commercial promise and a more stable overall business environment.Competitive Landscape The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
The Pharmaceutical Market: Kenya
Published on January 2013
Report Summary
Espicom market intelligence, brought to you by Business Monitor International
Kenya Pharmaceuticals & Healthcare Report
A high birth rate due to limited birth control and the importance placed on having a large family by rural populations as a source of
economic strength, as well as a growing disease burden, is likely to put further pressure on Kenya's healthcare infrastructure and
human resources. In order to provide the country's citizens with sufficient care, it is vital that the government adopts a human
resources strategy that incentivises medical workers so the sector can attract and retain staff.
Headline Expenditure Projections
Pharmaceuticals: KES41.74bn (US$470mn) in 2011 to KES49.70bn (US$577mn) in 2012; 19.1% growth in local currency terms and
22.9% in US dollar terms.
Healthcare: KES135.01bn (US$ 1.52bn) in 2011 to KES151.00bn (US$1.75bn) in 2012; 11.8% growth in local currency terms and
15.8% in US dollar terms.
Medical devices: KES7.19bn (US$81mn) in 2011 to KES7.68bn (US$89mn) in 2012; 6.8% growth in local currency terms and 10.2%
in US dollar terms.
Risk/Reward Rating: In BMI's Q113 Pharmaceutical and Healthcare Risk/Reward Ratings (RRRs), Kenya is 22nd in the Middle East
and Africa (MEA) region, above Uganda, Nigeria and Mozambique. A large counterfeiting industry, poor healthcare funding,
corruption, regulatory deficiencies and a number of other issues will conspire to keep Kenya in a lowly position in the MEA matrix.
Nevertheless, in comparison with many other African markets, most of which are not surveyed by BMI, Kenya offers more commercial
promise and a more stable overall business environment.
Competitive Landscape
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales -
for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Table of Content
Table of Contents
Executive Summary 5
SWOT Analysis 7
The Pharmaceutical Market: Kenya (From Slideshare) Page 1/5

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Kenya Pharmaceuticals And Healthcare Industry SWOT 7
Kenya Political SWOT 8
Kenya Economic SWOT 8
Kenya Business Environment SWOT 9
Pharmaceutical Risk/Reward Ratings 10
Table: MEA Pharmaceutical And Healthcare Risk/Reward Ratings, Q113 10
Rewards 11
Risks 12
Kenya ' Market Summary 13
Regulatory Regime 15
Intellectual Property 15
Pricing And Reimbursement Regime 16
Industry Trends And Developments 18
Epidemiology 18
Healthcare Provision 19
Healthcare Sector Financing 20
Health Insurance 22
Private Healthcare 25
Supply Chain 25
Medical Devices 28
Clinical Trials 29
Industry Forecast Scenario 31
Overall Market Forecast 31
Table: Pharmaceutical Sales, 2008-2016 32
Key Growth Factors ' Industry 33
Table: Overall Healthcare Expenditure, 2008-2016 34
Table: Government Healthcare Expenditure, 2008-2016 34
Table: Private Healthcare Expenditure, 2008-2016 35
Key Growth Factors ' Macroeconomic 36
Table: Kenya Economic Activity, 2011-2012 40
Prescription Drug Market Forecast 41
Table: Prescription Drug Sales, 2008-2016 42
Patented Drug Market Forecast 43
Table: Patented Drug Market Indicators 2008-2016 43
Generic Drug Market Forecast 44
Table: Generic Drug Sales, 2008-2016 45
OTC Medicine Market Forecast 46
Table: OTC Medicine Sales, 2008-2016 47
Medical Device Market Forecast 48
Table: Medical Device Sales, 2008-2016 49
Pharmaceutical Trade Forecast 50
Table: Pharmaceutical Trade, 2008-2016 51
Other Healthcare Data Forecasts 52
Key Risks To BMI's Forecasts 54
Competitive Landscape 56
Pharmaceutical Industry Activity 56
Company Profiles 58
Local Companies 58
The Pharmaceutical Market: Kenya (From Slideshare) Page 2/5

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Dawa Limited 58
Universal Corporation Limited 60
Shelys Pharmaceuticals 62
Regal Pharmaceuticals 63
High Chem East Africa 63
Multinational Companies 64
GlaxoSmithKline 64
Pfizer 66
Novartis 68
Sanofi 70
Merck & Co 72
Demographic Outlook 73
Table: Kenya's Population By Age Group, 1990-2020 ('000) 74
Table: Kenya's Population By Age Group, 1990-2020 (% of total) 75
Table: Kenya's Key Population Ratios, 1990-2020 76
Table: Kenya's Rural And Urban Population, 1990-2020 76
Glossary 77
BMI Methodology 79
How We Generate Our Pharmaceutical Industry Forecasts 79
Pharmaceuticals Risk/Reward Ratings Methodology 80
Ratings Overview 80
Table: Pharmaceutical Risk/Reward Indicators 81
Weighting 82
Table: Weighting Of Components 82
Sources 82
The Pharmaceutical Market: Kenya (From Slideshare) Page 3/5

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
The Pharmaceutical Market: Kenya
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 397.25 Quantity: _____
Site License--USD 2 794.50 Quantity: _____
Corporate License--USD 8 383.50 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
The Pharmaceutical Market: Kenya (From Slideshare) Page 4/5

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
The Pharmaceutical Market: Kenya (From Slideshare) Page 5/5